Novo’s Promising China Obesity Drug Records Mid-Stage Trial Win

An experimental drug Novo Nordisk licensed last year has shown notable weight loss in a mid-stage study in China, boosting the company’s search for newer products that could sustain its growth in the obesity market....

Redirecting to full article...